Clinical Trial

Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease

Name: Study of Roxadustat's Effect on Anemia in Patients With Diabetic Kidney Disease — clinical trial record (NCT07359027)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 4

View on ClinicalTrials.gov →

Summary

This study is a single-arm, open-label, multicenter and prospective study, which is conducted to evaluate the effect of Roxadustat on anemia in subjects with DKD (stage III-IV).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-13.

Trial Details

NCT Number	NCT07359027
Lead Sponsor	Second Xiangya Hospital of Central South University Collaborators: Xiangya Hospital of Central South University, The Third Xiangya Hospital of Central South University
Conditions	Diabetic Kidney Disease, Anemia
Enrollment	124 participants
Start Date	2021-11-02
Primary Completion	2022-12-31 (estimated)
Study Completion	2024-07-08 (estimated)
Updated on ClinicalTrials.gov	2026-01-26